Effects of recombinant methionyl bovine somatotropin (sometribove) in high producing cows milked three times daily

The Impacts of Climate Change Mitigation Strategies on Animal Welfare

The objective of this review is to point out that the global dialog on reducing greenhouse gas emissions in animal agriculture has, thus far, not adequately considered animal welfare in proposed climate change mitigation strategies. Many suggested approaches for reducing emissions, most of which could generally be described as calls for the intensification of production, can have substantial effects on the animals. Given the growing world-wide awareness and concern for animal welfare, many of these approaches are not socially sustainable. This review identifies the main emission abatement strategies in the climate change literature that would negatively affect animal welfare and details the associated problems. Alternative strategies are also identified as possible solutions for animal welfare and climate change, and it is suggested that more attention be focused on these types of options when allocating resources, researching mitigation strategies, and making policy decisions on reducing emissions from animal agriculture.

Meta-analysis of the effects of sometribove zinc suspension on the production and health of lactating dairy cows

OBJECTIVE

To provide an updated evaluation of the efficacy and safety of sometribove zinc suspension (rbST-Zn), a form of recombinant bovine somatotropin, in lactating dairy cows.

DESIGN

Meta-analysis.

SAMPLE

26 studies published in peer-reviewed journals or reviewed by a regulatory agency.

PROCEDURES

To be included, a study had to involve the use of the rbST-Zn formulation available to US producers in accordance with the label instructions for treatment initiation (57 to 70 days postpartum), dose (500 mg, q 14 d), and route (SC).

RESULTS

For cows treated with rbST-Zn, mean milk, 3.5% fat-corrected milk, fat, and protein yields were increased by 4.00, 4.04, 0.144, and 0.137 kg/d (8.8, 8.89, 0.32, and 0.30 lb/d), respectively; however, the concentration of milk components did not change. Pregnancy proportion for the first 2 breeding cycles was increased by 5.4%, and pregnancy proportion for the duration of the trial was reduced by 5.5% for rbST-Zn-treated cows, compared with proportions for untreated cows. Mean body condition score (1 to 5 scale) was reduced by 0.06 points during the period of rbST-Zn use for treated cows. Administration of rbST-Zn had no effect on milk somatic cell count, the number of days to pregnancy, or inseminations per pregnancy; rates of fetal loss, twins, cystic ovaries, clinical lameness, lameness lesions, or traumatic lesions of the integumentary system; and odds of clinical mastitis or culling.

CONCLUSIONS AND CLINICAL RELEVANCE

Results indicated that rbST-Zn administration to dairy cows effectively increases milk production with no adverse effects on cow health and well-being.

Separate and additive stimulation of bovine milk yield by the local and systemic galactopoietic stimuli of frequent milking and growth hormone

Lactating heifers were treated for 4 weeks with recombinant bovine growth hormone (bGH, n = 9) or were untreated (n = 9). In addition, two mammary glands of each heifer were milked four times daily rather than the normal twice daily for the same 4 weeks, and for the following 2 weeks. Over the 4 weeks, milk yield was increased 12·8% by bGH, 14·0% by frequent milking and 28·5% by the combined treatment. The effect of bGH as administered here was slower in onset than that of frequency, but eventually produced a higher peak yield. ANOVA revealed significant effects of each stimulus independently and an additive, but not synergic effect of the combined treatment. The effect of the combined treatment tended to persist beyond the end of treatment; most of this response was related to the milking frequency component rather than the bGH. Mammary differentiation was assessed in biopsies of mammary tissue obtained prior to and at the end of treatment. Mammary enzyme activities (expressed on a per cell basis) indicated minimal differentiative response to either treatment, but synthesis rates for lactose and casein determined in vitro were increased by bGH treatment. Histological examination revealed a stimulatory effect of milking frequency on epithelial cell size. The results indicate that these two galactopoietic stimuli operate through independent mechanisms, and neither stimulus alone is sufficient to maximize milk yield in dairy heifers.

Genetic parameters for yield traits of cows treated or not treated with bovine somatotropin

The objective of this study was to estimate genetic correlations between yield traits of cows treated with bovine somatotropin (bST) and the same yield traits of untreated cows. Lactation records from registered Holstein cows were divided by parity into 3 data sets: 1, 2, and 3 through 5. Approximately 10% of the records in each data set were from cows treated with bST. The numbers of records of treated and untreated cows in the data sets were 4,337 and 48,765; 3,730 and 37,796; and 3,645 and 33,957. Two-trait animal models (records for cows treated or not treated) were used to estimate genetic parameters for milk production traits and somatic cell score (SCS). Estimates of heritability for milk yield for records of treated and untreated cows for the 3 data sets were 0.13, 0.16, and 0.09, and 0.18, 0.18, and 0.14, respectively, with estimates of repeatability of 0.50 and 0.41 for data set 3. Estimates of heritability for fat yield for records of treated and untreated cows were 0.31, 0.16, and 0.12, and 0.27, 0.21, and 0.16. Estimates of repeatability were 0.50 and 0.43 for data set 3. Heritability estimates for protein yield for records of treated and untreated cows were 0.13, 0.17, and 0.12, and 0.20, 0.23, and 0.16, with estimates of repeatability of 0.52 and 0.47. Estimates of heritability for SCS for treated and untreated cows were 0.08, 0.15, and 0.13, and 0.11, 0.13, and 0.13 with repeatability estimates of 0.52 and 0.45. Estimates of genetic correlations between milk yields with and without bST treatment in lactations 1, 2, and 3 to 5 were all 0.99. Estimates of genetic correlations for fat and protein yields were 0.96 for all data sets. Estimates for SCS were 0.99. Estimates of genetic correlations between records of treated and untreated cows were large enough to conclude that records of treated and untreated cows could be considered to be one trait, with treatment as a fixed effect to account for differences in means.

Modeling milk production and labor efficiency in modernized Wisconsin dairy herds

The 1999 Wisconsin Dairy Modernization Project was conducted to examine variation in milk production and labor efficiency among herds that had recently expanded. Data were obtained from a sample of Wisconsin herds that expanded between 1994 and 1998. Using rolling herd average milk production in 1998 as the dependent variable in the milk production model, milking frequency, bovine somatotropin use, sprinkler use, average linear somatic cell score, average age at first calving, average days dry, and rolling herd average milk production in 1994 predicted 69% of the variation in milk production. Milking three times daily, using bovine somatotropin, using sprinklers to cool cows, and decreasing linear somatic cell score, age at first calving, and days dry were associated with increased milk production. Each of these variables supports previous research from designed experiments with on-farm results. Variation in milk production is determined primarily by differences in management ability and management practices employed by the dairy producer. Using cows per full-time equivalent as the dependent variable in the labor efficiency model, acres per cow, number of people involved in the milking operation, milking system type, herd size, and interactions between milking system types and herd size predicted approximately 43% of the variation in labor efficiency. As expected, labor efficiency increased with larger herd sizes, fewer acres per cow, and fewer people involved in the milking process. Parallel milking parlors were associated with the highest cows per full-time equivalent followed by herringbone parlors, flat barns, and stall barns.

Bias in genetic evaluations by records of cows treated with bovine somatotropin

Records from Dairy Records Management Systems in Raleigh were used to estimate effects of bovine somatotropin (bST) treatment and to predict breeding values for milk production traits. The data comprised 5245 test-day records of bST-treated cows and 126,223 test-day records of untreated cows in first lactation for milk, fat, and protein yields. Fixed effects of bST treatment were estimated from test-day animal models with herd-test-date as another fixed factor. Percentage increases due to bST treatment ranged from 7 to 8% for test-day milk, fat, and protein yields. Random regression coefficients for additive genetic and permanent environmental effects were included in the model. To assess the potential for bias in genetic evaluations when some and not all cows are treated with bST, breeding values predicted by the test-day model with and without effects of bST treatment were compared for cows and sires. Correlations between breeding values predicted from models with and without effects of bST treatment were 0.99. However, relatively large bias was found for individual animals. This result suggests that bias in genetic evaluation caused by ignoring bST treatment may be significant.

Simulated effects on dairy cattle health of extending the voluntary waiting period with recombinant bovine somatotropin

We simulated the effect of extending the voluntary wait period by 100 days on disorder-frequency measures that were based on cow-years (from lactations completed during the 4-year simulation horizon), metric tons of milk yield, and lactational incidence risks. A dynamic stochastic discrete-event simulation model that focuses on clinical and subclinical intramammary infections (IMI), plus clinical metabolic (left-displaced abomasum, ketosis, milk fever) and reproductive (cystic ovarian disease, dystocia, retained placenta, twinning, uterine infection) disorders in dairy herds was used. Although the voluntary wait period was increased by 100 days (50 vs. 150), the predicted difference in simulated days to conception was only 89 days for the extended voluntary wait-period group (which we attributed to higher fertility later in lactation). Herds that had a voluntary wait period of 150 days (compared to the control herds' voluntary wait period of 50 days) were predicted to have significantly lower rates of metabolic and reproductive disorders and clinical mastitis on both cow-year and milk-yield bases. Simulated control herds, on average, produced 8539 kg of milk in an average lactation of 325 days and simulated herds with a 150-day voluntary wait period 10893 kg of milk in an average lactation of 409 days. There was a significantly lower predicted rate and risk of culling for reproductive failure in the extended voluntary wait period group. The predicted lactational incidence risks for subclinical IMI were 18% higher for the extended voluntary wait period group - but extending the voluntary wait period by 100 days was predicted not to increase the risk of any of the other 10 disorders.

Responses of dairy cows supplemented with somatotropin during weeks 5 through 43 of lactation

Beginning at wk 5 of lactation, 136 cows (34 per treatment) were supplemented daily for 38 wk with 0, 10.3, 20.6, or 41.2 mg of recombinantly derived bST monomer. Cows were obtained from University of Kentucky, University of Minnesota, University of Pennsylvania, and The Ohio State University. Nine cows (4 at 0 mg/d, 1 at 10.3 mg/d, 1 at 20.6 mg/d, and 3 at 41.2 mg/d) did not complete the experiment because of health problems. Data from these cows were included in the reproduction and health databases but not in the production database. Cows supplemented with bST produced more milk, consumed more feed, had lower rates of BW gain, and had improved efficiencies of milk production (conversion of feed and NEL to milk). Additional increases in productivity were modest at 20.6 and 41.2 mg/d versus productivity at 10.3 mg/d of bST. Concentrations of fat, protein, and TS in milk were unaffected. At 10.3 mg/d, bST did not adversely affect reproduction or health.

Production responses of cows to recombinantly derived bovine somatotropin and to frequency of milking

To determine whether bST additively increases milk production in cows milked at different frequencies per day, 118 Holstein primiparous and multiparous cows were milked two or three times daily beginning at parturition and received either 14 mg of bST or no injection beginning at d 75 of lactation. Increased milking frequency from two to three times daily increased 3.5% FCM in multiparous (4.7 kg/d) and primiparous (4.1 kg/d) cows over 305 d. Injection of bST increased FCM 4.3 kg/d in multiparous cows and 5.0 kg/d in primiparous cows over 230 d. Increased milking frequency from two to three times daily reduced milk fat and protein percentages in milk, but bST generally did not affect these percentages. Injection of bST prevented increases in body condition score as lactation advanced, but increasing milking frequency from two to three times daily did not. In general, bST and increased milking frequency additively increased FCM in multiparous and primiparous cows.

Effects of recombinant bovine somatotropin under conditions of high production and heat stress

The effect of bST injection on milk production of Israeli Holsteins was tested under conditions of mean production > 9000 kg/yr and climatic stress; mean maximum and minimum summer temperatures are 38 and 25 degrees C, respectively, in the Jordan Valley, located 200 m below sea level. In 1989, 111 cows were injected, and 115 cows were recorded as controls. In 1990, 108 cows were injected, and 93 cows were included as controls. Fifty-nine of the cows injected in 1990 were also injected in 1989. Production records were corrected for parity, calving month, days to first injection, and days in milk. Injection with bST increased total lactation milk production by 12%, fat production by 15%, and protein production by 13%. Injection also resulted in slight increases in fat and protein percentages. Daily milk production during the injection period was increased by 4.4 kg. Injection during the previous lactation slightly decreased production of cows injected during the following lactation. Advancing the commencement of injection from the 4th to the 2nd mo in milk did not affect total lactation production. Weight gains and dry matter intake were higher for injected cows, but body condition score was higher for the control group. Injection had no discernible effect on fertility variables.